Nabel Gary J.'s Form 4 filing
Opko Health, Inc. (OPK) · filed May 19, 2022
- Accession no.
- 0001209191-22-030517
- Filed
- May 19, 2022
- Trade date
- May 12-18, 2022
- Filing delay
- 7 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market purchases total $217.1K. It was filed 7 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Nabel Gary J.CIK 0001867450 | Director, Officer (Chief Innovation Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 12, 2022 | Common Stock | PPurchaseAcquired | +6,979 | $2.65 | +$18,494.35 | 6,979 | Direct | |
| May 18, 2022 | Common Stock | PPurchaseAcquired | +68,492 | $2.90 | +$198,626.8 | 75,471 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.